You are here

Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia A
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
12 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Severe hemophilia A (FVIII:C

- Previously treated patients (PTP) with at least 250 exposure days to any factor VIII
product

- Age greater than or equal to 12 years\

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- The presence of any bleeding disorder in addition to hemophilia A

- Concomitant therapy with immunosuppressant drugs (e.g., intravenous immunoglobulin
(IVIG), routine systemic corticosteroid use)

- History of detectable factor VIII inhibitor

NCT00038935
Pfizer
Completed
Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Hemophilia A or B
NCT03363321
Males
12+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now